TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2011

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 192 53.5 7.3 (39.2 – 67.8) 210 57.5 6.8 (44.2 – 70.8)
Arizona 228 53.0 7.5 (38.3 – 67.7) 249 50.8 7.2 (36.7 – 64.9)
California 506 47.6 3.7 (40.3 – 54.9) 535 47.5 3.3 (41.0 – 54.0)
Connecticut 252 50.2 5.9 (38.6 – 61.8) 277 47.2 5.5 (36.4 – 58.0)
District of Columbia 151 49.5 7.3 (35.2 – 63.8) 169 49.0 7.0 (35.3 – 62.7)
Florida 367 50.9 5.8 (39.5 – 62.3) 416 47.2 5.4 (36.6 – 57.8)
Georgia 261 31.8 6.1 (19.8 – 43.8) 270 32.3 6.0 (20.5 – 44.1)
Hawaii 246 43.8 6.1 (31.8 – 55.8) 257 47.3 6.0 (35.5 – 59.1)
Illinois 175 47.6 7.2 (33.5 – 61.7) 186 47.4 6.9 (33.9 – 60.9)
Indiana 330 50.9 4.5 (42.1 – 59.7) 342 51.7 4.5 (42.9 – 60.5)
Iowa 197 61.0 6.2 (48.8 – 73.2) 206 59.9 6.1 (47.9 – 71.9)
Kansas 737 50.7 3.5 (43.8 – 57.6) 761 51.8 3.4 (45.1 – 58.5)
Louisiana 267 51.6 7.3 (37.3 – 65.9) 282 47.3 7.4 (32.8 – 61.8)
Maine 272 63.6 5.3 (53.2 – 74.0) 295 59.1 5.2 (48.9 – 69.3)
Maryland 211 42.1 5.4 (31.5 – 52.7) 224 41.6 5.2 (31.4 – 51.8)
Massachusetts 237 46.1 6.6 (33.2 – 59.0) 249 45.5 6.4 (33.0 – 58.0)
Michigan 498 64.2 4.1 (56.2 – 72.2) 544 60.9 4.0 (53.1 – 68.7)
Mississippi 262 40.2 6.0 (28.4 – 52.0) 278 41.7 5.8 (30.3 – 53.1)
Missouri 218 59.7 6.3 (47.4 – 72.0) 221 59.4 6.5 (46.7 – 72.1)
Montana 340 45.5 4.6 (36.5 – 54.5) 353 41.8 4.6 (32.8 – 50.8)
Nebraska 665 49.6 4.1 (41.6 – 57.6) 713 47.2 3.9 (39.6 – 54.8)
Nevada 134 63.9 8.1 (48.0 – 79.8) 141 61.9 8.1 (46.0 – 77.8)
New Hampshire 222 56.5 5.7 (45.3 – 67.7) 238 51.3 6.0 (39.5 – 63.1)
New Jersey 343 44.6 5.0 (34.8 – 54.4) 367 42.5 4.8 (33.1 – 51.9)
New Mexico 316 55.6 5.5 (44.8 – 66.4) 340 53.5 5.2 (43.3 – 63.7)
New York 135 53.5 6.8 (40.2 – 66.8) 146 53.5 6.2 (41.3 – 65.7)
North Carolina 229 51.0 5.7 (39.8 – 62.2) 241 52.4 5.6 (41.4 – 63.4)
North Dakota 176 53.9 7.4 (39.4 – 68.4) 186 53.9 7.2 (39.8 – 68.0)
Ohio 325 58.1 5.8 (46.7 – 69.5) 336 59.9 5.5 (49.1 – 70.7)
Oklahoma 295 59.8 4.9 (50.2 – 69.4) 312 62.5 4.2 (54.3 – 70.7)
Oregon 183 70.9 5.3 (60.5 – 81.3) 199 66.2 5.5 (55.4 – 77.0)
Pennsylvania 380 47.6 4.6 (38.6 – 56.6) 412 46.8 4.3 (38.4 – 55.2)
Rhode Island 248 48.9 5.4 (38.3 – 59.5) 270 45.1 5.2 (34.9 – 55.3)
Texas 521 53.2 4.6 (44.2 – 62.2) 570 53.0 4.1 (45.0 – 61.0)
Utah 410 53.8 4.6 (44.8 – 62.8) 454 51.1 4.5 (42.3 – 59.9)
Vermont 306 53.4 4.5 (44.6 – 62.2) 315 52.3 4.5 (43.5 – 61.1)
Washington 664 52.0 3.4 (45.3 – 58.7) 666 53.0 3.2 (46.7 – 59.3)
West Virginia 197 51.0 5.6 (40.0 – 62.0) 200 51.5 5.5 (40.7 – 62.3)
Wisconsin 244 56.7 6.0 (44.9 – 68.5) 244 59.0 6.1 (47.0 – 71.0)
Puerto Rico 293 24.3 3.8 (16.9 – 31.7) 323 23.6 3.6 (16.5 – 30.7)
40 state total 12,233 50.9 1.2 (48.5 – 53.3) 12,997 50.3 1.1 (48.1 – 52.5)
Median   51.3       51.4    
Range   24.3-70.9       23.6-66.2    

1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
Confidence interval